Help ?

IGMIN: We're glad you're here. Please click 'create a new query' if you are a new visitor to our website and need further information from us.

If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click 'take me to my Query.'

Search

Organised by  IgMin Fevicon

Regional sites

Browse by Subjects

Welcome to IgMin Research – an Open Access journal uniting Biology, Medicine, and Engineering. We’re dedicated to advancing global knowledge and fostering collaboration across scientific fields.

Browse by Sections

At IgMin Research, we bridge the frontiers of Biology, Medicine, and Engineering to foster interdisciplinary innovation. Our expanded scope now embraces a wide spectrum of scientific disciplines, empowering global researchers to explore, contribute, and collaborate through open access.

Special Issues

We endeavor to cultivate dialogue that spans multiple scientific disciplines to fast-track innovation.

Members

We endeavor to cultivate dialogue that spans multiple scientific disciplines to fast-track innovation.

Articles

We endeavor to cultivate dialogue that spans multiple scientific disciplines to fast-track innovation.

Explore Content

We endeavor to cultivate dialogue that spans multiple scientific disciplines to fast-track innovation.

Identify Us

We endeavor to cultivate dialogue that spans multiple scientific disciplines to fast-track innovation.

IgMin Corporation

Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.

Publications Support
[email protected]
E-Books Support
[email protected]
Webinars & Conferences Support
[email protected]
Content Writing Support
[email protected]
IT Support
[email protected]

Search

Select Language

Explore Section

Content for the explore section slider goes here.

Table of Contents

Table of Contents at IgMin Research

We endeavor to cultivate dialogue that spans multiple scientific disciplines to fast-track innovation.

Article Explorer

Search by
Clear

All Articles
Most Recent Most Viewed Most Downloaded
5 of 246 results
Cannabidiol: The
Perspective February 18, 2026

Cannabidiol: The "Trojan Horse" of our times

A Multi-Model Simulation Framework for Sponge Park Concept Achieving Urban Water Energy Nexus Sustainability in Hyper Arid Climates
Research Article February 03, 2026

A Multi-Model Simulation Framework for Sponge Park Concept Achieving Urban Water Energy Nexus Sustainability in Hyper Arid Climates

Landing Site Selection for the First Human Mission to Mars
Research Article February 09, 2026

Landing Site Selection for the First Human Mission to Mars

Immobilization of 7-Iodo-8-hydroxyquinoline-5-sulfonic Acid (Ferron): A Comprehensive Review of Techniques and Applications
Research Article February 04, 2026

Immobilization of 7-Iodo-8-hydroxyquinoline-5-sulfonic Acid (Ferron): A Comprehensive Review of Techniques and Applications

From Test Case Design to Test Data Generation: How AI is Transforming End-to-End Quality Assurance in Agile and DevOps Environments
Research Article February 03, 2026

From Test Case Design to Test Data Generation: How AI is Transforming End-to-End Quality Assurance in Agile and DevOps Environments

Article Preview Metrics Cite
Published: February 18, 2026 (190d) publication certificate
Cannabidiol: The Perspective

Cannabidiol: The "Trojan Horse" of our times

George Albert Karikas*

The spread in humans is considered one of the most studied issues among other illicit products. Nevertheless, cannabis/cannabinoids' safety remains unsolved and controversial. Cannabidiol, a component of recreational cannabis, is now found in a multitude of legal or illegal medicinal cannabis preparations, dietary supplements, foods, cosmetics, etc., in uncontrollable combinations with the psychoactive tetrahydrocannabinol (THC). Despite the conflicting findings of many research groups regarding the safe administration of cannabinoids in general, in all age/race groups, these limitations have not been particularly emphasized. Fortunately, the significant increase in its consumption in the elderly has led reliable international organizations to strongly question the long-term cannabidiol toxicological "immunity", highlighting these risks by classifying it as a particularly CMR substance (ANSES). Serious elderly problems have also been recently recorded, especially at dosages greater than 2mg/day of Cannabidiol (EFSA). In this short article, some of the Cannabidiol receptors, their potential therapeutic applications, side effects, and their interactions with prescription drugs/comorbidities are listed.
In conclusion, Cannabidiol must immediately be addressed by law, as a multi-potent and not harmless drug, with the aim of an effective measure against the public and individual health "invisible siege", on a global scale, otherwise its negative cost outweighs any healing benefit.